Clinical trial
US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice
NCT02126943 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice
- Lead sponsor
- Actelion
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- April 24, 2020
- Enrollment
- 2,686 (actual)
- Sites
- 146
Conditions
As the registry lists them; a condition with its own page is linked.